Lewes, DE -- (SBWire) -- 08/15/2013 --LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Cheung Kong (Holdings) Limited (ADR)(OTCMKTS:CHEUY), SK3 Group Inc(NDA)(OTCMKTS:SKTO), Senesco Technologies, Inc.(OTCBB:SNTI), IntelGenx Technologies Corp.(OTCMKTS:IGXT)

Cheung Kong (Holdings) Limited (ADR)(OTCMKTS:CHEUY) ended lower -1.01% and complete the day at $14.75. The total number of shares changed hands during the day was 109,783. After opening at $14.82, the stock hit as high as $14.91. However, it traded between $12.28 and $17.11 over the last twelve months.

Cheung Kong (Holdings) Limited is a Hong Kong-based company engaged in investment holding and project management. The Company’s subsidiaries are engaged in property development and investment, hotel and serviced suite operation, property and project management, and investment in infrastructure business. It is also engaged in information technology, e-commerce and new technology.

Has CHEUY Found The Bottom and Ready To Move Up?Find Out Here

SK3 Group Inc(NDA)(OTCMKTS:SKTO) closed yesterday at $0.0013, a -8.13% decrease. Around 8.76 million shares were traded, beating an-average trading volume of 2.86 million shares. The company is now valued at around $4.34 million.

SK3 Group, Inc. (SK3), formerly CTT International Distributors Inc., is a development-stage company. The Company was formed by the merger of Slabsdirect.com, Inc. and CTT International Distributors Inc. SK3 has one subsidiary, CTT Distributors Ltd., which is the operating company.

Has SKTO Found The Bottom And Ready To Gain Momentum?Find Out Here

Senesco Technologies, Inc.(OTCBB:SNTI) moved -10.00 percent lower at $0.0450 and traded between $0.04 and $0.05 after opening the day at $0.05. Its performance over the last five days remained -63.11%, which stands at -63.11% for a month. Going back further than one month, 1-year performance after recent close was -63.11%.

Senesco Technologies, Inc. is engaged in utilize its eukaryotic translation initiation Factor 5A, or Factor 5A, and deoxyhypusine synthase (DHS), and related technologies for human therapeutic applications to develop approaches to treat cancer and inflammatory diseases. In agricultural applications

Why Should Investors Buy SNTI After the Recent Fall? Just Go Here and Find Out

IntelGenx Technologies Corp.(OTCMKTS:IGXT) shares fall, losing -4.59 percent to close at $.0582. The stock is down around -10.46% this year and 3.93% for the last 12 months. Around 257,918 shares changed hands yesterday, lower from an-average trading volume of 294,357 shares.

IntelGenx Technologies Corp. (IntelGenx) is a drug delivery company focusing on the development of orally administered drug delivery products based on its oral drug delivery technologies.

Will IGXT Get Buyers Even After The Recent Rally? Find Out Here

About LeadingStockAlerts:
LeadingStockAlertsis a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/